Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Solesence (SLSN) EBITDA (2016 - 2025)

Solesence's EBITDA history spans 16 years, with the latest figure at -$994000.0 for Q4 2025.

  • For Q4 2025, EBITDA fell 345.74% year-over-year to -$994000.0; the TTM value through Dec 2025 reached $391000.0, down 92.38%, while the annual FY2025 figure was $392000.0, 92.36% down from the prior year.
  • EBITDA reached -$994000.0 in Q4 2025 per SLSN's latest filing, down from -$781000.0 in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $3.2 million in Q3 2024 to a low of -$1.2 million in Q3 2023.
  • Average EBITDA over 5 years is $330650.0, with a median of $189500.0 recorded in 2022.
  • Peak YoY movement for EBITDA: surged 1255.81% in 2021, then tumbled 1056.19% in 2023.
  • A 5-year view of EBITDA shows it stood at -$299000.0 in 2021, then soared by 51.51% to -$145000.0 in 2022, then skyrocketed by 602.07% to $728000.0 in 2023, then crashed by 130.63% to -$223000.0 in 2024, then plummeted by 345.74% to -$994000.0 in 2025.
  • Per Business Quant, the three most recent readings for SLSN's EBITDA are -$994000.0 (Q4 2025), -$781000.0 (Q3 2025), and $1.9 million (Q2 2025).